What “Conforms to Specification” Requires

Overview

Short answer: For a report to support a claim that a product “conforms to specification” under Health Canada’s model, it must show (a) the specification itself (defined tests, procedures and acceptance criteria), (b) the actual test procedures used to generate results, and (c) the measured results compared against the stated acceptance criteria. Each of those elements must be documented so a reader can verify that the results were obtained by the specified methods and assessed against the specified limits; absent any one element, the report cannot reliably support a conformance claim .

Why this matters: Health Canada’s quality guidance and GMP-related documents treat “specification” as a bundle of test methods, procedures and acceptance criteria that, together with actual test outcomes, form the evidence that a batch or product meets its defined quality attributes. The following sections explain what to look for in a report, how to read the evidence, and what remains unresolved by such a report alone (including legal or authorization status) .

What the specification must include

What the report must show about the procedures used

How results must be presented and assessed

A simple evidentiary checklist to read a conformance report

Use the checklist to judge whether a report contains the minimum elements required to support “conforms to specification.”

What such a report does not establish

How to use this in practice Read reports with the checklist in hand. Verify that the specification document and method versions are present, that raw or traceable data support reported results, and that each result is explicitly compared to an acceptance criterion. Where any element is missing, treat a conformance claim as unsupported until that evidentiary gap is closed. If you require confirmation about a product’s authorization or regulatory compliance, consult Health Canada’s public databases or regulatory contacts—an analytical report alone does not supply that information .

• Defined tests and attributes: A specification lists the attributes to be tested (identity, potency, purity, impurities, dissolution, microbial limits, etc.) and associates each attribute with a defined test or assay. The specification is meaningful only if each attribute is paired with a specific analytical or procedural method .
• Numerical or categorical acceptance criteria: For each test there must be an acceptance criterion—numerical limits, ranges, or pass/fail criteria—that state what constitutes conforming versus non-conforming. Acceptance criteria can be absolute values, ranges, limits for impurities, or categorical statements (e.g., “no growth observed”) .
• Reference to procedures and methods: The specification should point to the test procedures or analytical methods (e.g., validated HPLC method, microbiological method, identity test). Those procedures may be described in-line or referenced to an approved compendium, validated method report, or internal method document. A specification that names tests but omits methods leaves a key evidentiary gap .
• Method identification and versioning: The report should identify exactly which method version or procedure was used for each test. Method title alone is insufficient if multiple versions exist; version numbers, revision dates or controlled-document IDs are needed to tie results to the method used .
• Evidence of method execution: The report should show that the procedure was followed—e.g., sample preparation steps, instrument settings, calibration status, reagents used, and any deviations. Where the method references validation or acceptance criteria for the method itself, the report should indicate whether the method was operating within validated parameters at test time .
• Chain-of-data elements: Good reports include raw data or summarized analytical outputs (chromatograms, spectra, colony counts), operator initials, instrument identifiers, and timestamps so the reader can see the data flow from method to result; Health Canada guidance emphasizes traceability and documentation in GMP contexts .
• Direct comparison to acceptance criteria: For each test, the report must present the measured result(s) and show whether they meet the stated acceptance criterion. That means reporting numerical results with units, limits, and an explicit pass/fail determination tied to the specification .
• Treatment of out-of-specification data: If a result falls outside criteria, the report should present investigations, reanalyses, or justification for acceptance if an alternate justification is claimed. A bare assertion of “conforms” despite out-of-specification results is not evidentiary without documented investigation and resolution .
• Statistical and sampling context: Where specifications involve averages, variability, or acceptance sampling, the report should disclose sample size, sampling plan, statistical methods used, and how conformance was assessed across the sample set. A single-point result cannot establish conformance where the specification anticipates aggregated or statistical evaluation .
• Is the specification document included or clearly cited, showing tests, methods, and acceptance criteria?
• Are the precise test methods (with version/revision) used to generate results identified?
• Are the raw or summarized analytical results presented with units and uncertainty where relevant?
• Is there a clear comparison between each result and its acceptance criterion, with an explicit pass/fail determination?
• If deviations or out-of-specification results exist, are investigations and their conclusions documented?
• Authorization or legal status: An analytical or quality report demonstrating that test results meet a specified set of criteria does not by itself establish that a product is authorized for sale, marketed lawfully in Canada, or compliant with regulatory approvals. Authorization requires separate regulatory submissions and approvals, which are documented in Health Canada systems and databases; an analytical result is evidence about a sample’s characteristics, not a substitute for regulatory status .
• Batch-wide uniformity or sterility proof: A single report may document results for a lot or sample but does not prove ongoing batch uniformity, manufacturing control across time, or absence of contaminants beyond the samples tested. Likewise, specific laboratory findings—even with certificates or numeric assay values—do not prove sterility or safety beyond the tested samples. Such inferences require broader sampling, validated processes, and regulatory review .
• Legal or compliance interpretation: The guidance documents and GMP materials describe expectations and practices; they are not legal advice. If you need a legal determination about authorization, labeling, or marketing, consult legal counsel or regulatory authorities. The present discussion explains evidence requirements under Health Canada’s specification model as of 2026-09-25 and is analytical, not legal .